hotspot -WSS

hotspot

author：hotspot 2025-09-14 14:41:39 - browse：48

Chris O'Meara/AP

Johnson & Johnson faces a consequential new class action lawsuit — not in its role as a manufacturer of drugs, but as an employer and purchaser of prescription drugs for its workers.

Ann Lewandowski, a health care policy and advocacy director at J&J, sued her company on Monday for allegedly overpaying its pharmacy benefit manager for its employees’ medicines, citing previous STAT reporting to support some of the allegations. Those overpayments, the lawsuit alleges, ultimately come out of workers’ paychecks in the form of high health insurance premiums, higher out-of-pocket drug costs, and stunted wage growth.

In one example, J&J allegedly paid its PBM more than $10,000 for a single 90-day prescription of teriflunomide, a generic medicine for multiple sclerosis, when that same 90-day prescription could be purchased for as little as $30 elsewhere without insurance, according to the lawsuit.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Just how do doctors, lawmakers, and the public define abortion?

Wikipedia

WSS

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Headspace, Meta partner to launch VR meditation app for Quest

The drug industry has found itself all alone in Washington

Readout Newsletter: Illumina, CRISPR, Regeneron

In his State of the Union, Biden takes clear aim at 'Big Pharma'

focus

hotspot

Wikipedia

Heart attack and stroke risk calculators need revising

Testing GLP

Wildfire smoke exposes gaps in outdoor worker protections

Diabetes management: Digital health tools fall short, study says

Walensky prepares to leave CDC — and Congress — behind

With Wegovy coverage, Medicare patients may face high costs

The high cost of giving birth even with insurance

The drug industry has found itself all alone in Washington

After affirmative action ruling, medical educators look to 'holistic review'

With Wegovy coverage, Medicare patients may face high costs

focus

Air quality improving but still lags in Black, Hispanic communities

Pfizer, Moderna say biotech, pharma drug development is a sprint

Surgeons perform first xenotransplant using CRISPR'd pig kidney

First medicine developed to treat MASH expected to be approved soon

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Yancopoulos of Regeneron works to expand Dupixent success

Wikipedia

knowledge

focus

hotspot